Share ownership QuidelOrtho Corporation

QDEL

US2197981051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 12/12/2025 GMT			5-day change	1st Jan Change
28.80 ^USD	-2.90%		+3.75%	-35.35%

12-03	QuidelOrtho Corporation Presents at Citi Annual Global Healthcare Conference 2025, Dec-03-2025 01:00 PM
11-06	UBS Adjusts Price Target on QuidelOrtho to $31 From $26, Maintains Neutral Rating	MT

Share class: QuidelOrtho Corporation

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	67,256,717	66,272,267 ( 98.54 %)	0	98.54 %

Major shareholders: QuidelOrtho Corporation

Name	Equities	%	Valuation
T. Rowe Price Investment Management, Inc. 16.22 %	11,012,190	16.22 %	301 M $
BlackRock Advisors LLC 14.17 %	9,619,699	14.17 %	263 M $
Vanguard Fiduciary Trust Co. 11.25 %	7,636,193	11.25 %	209 M $
Rubric Capital Management LP 6.83 %	4,637,738	6.83 %	127 M $
Fidelity Management & Research Co. LLC 6.622 %	4,496,153	6.622 %	123 M $
Invesco Advisers, Inc. 4.281 %	2,906,763	4.281 %	79 M $
DFA Australia Ltd. 4.088 %	2,776,086	4.088 %	76 M $
Newtyn Management LLC 3.976 %	2,700,000	3.976 %	74 M $
STATE STREET CORPORATION 3.93 %	2,668,739	3.93 %	73 M $
American Century Cos., Inc. 3.116 %	2,115,557	3.116 %	58 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Breakdown by shareholder type

Institutional	106.97%
Other	8.91%
State Street Corp.	3.93%
Silvercrest Asset Management Group, Inc.	1.89%
Individuals	0.99%
SEI Investments Co.	0.23%
Schweizerische Nationalbank	0.19%
Manulife Financial Corp.	0.05%
Governments	0.04%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	110.25%
Australia	4.13%
United Kingdom	3.31%
Netherlands	1.32%
Canada	1.24%
Individuals	0.99%
United Arab Emirates	0.6%
Norway	0.5%
Switzerland	0.25%
Ireland	0.21%
Monaco	0.13%
Luxembourg	0.12%
Germany	0.06%
Sweden	0.05%
Czech Republic	0.03%
Spain	0.01%

Based on 1000 largest holdings

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

Employees

6,600

Sector

Advanced Medical Equipment & Technology

Calendar

02-17 - Q4 2025 Earnings Release (Projected)

More about the company